ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

DCCP To Have Board Of Scientific Counselors

September 1, 1978

In Brief: Rall Says He’ll Return Money To NCI If There Isn’t Any Left; OMB Releases 28 Positions For NTP

February 1, 1980

AACR Elects Officers.

April 9, 2010

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

December 7, 1990